EQ-5D and PROMs

19 March: Jon Sussex will be at BioWales 2013 speaking on the health and wider economic benefits of life sciences research. 21 March: Jorge Mestre-Ferrandiz will give his updated annual presentation on the economics of the market for medicines at City College in London. 21/22 March: Nancy Devlin will be in Singapore with EuroQol colleagues. Until 12 April, OHE is accepting applications for a fixed-term position for an economist. Keep up with the latest!

At a recent meeting of the Pharmaceutical Onology Initiative’s (POI) HTA group, OHE’s Nancy Devlin provided an overview of the EuroQol Group’s scientific research agenda for the coming year and plans for the EQ-5D-5L approach to measuring patient-reported outcomes of care.

In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined what may cause the two-cluster shape of EQ-5D indexes. This is important because these indexes are used widely in other analyses that affect health care resource decisions.

The OHE continues to play a central role in the development and use of patient-reported outcomes measures (PROMs). The last quarter of 2012 was characteristically busy.

OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield have been awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National Institute for Health Research (NIHR) for research to produce an EQ-5D-5L Value Set for England.

OHE team members have been active in a number of external seminars, conferences and workshops. These included gatherings of academic experts, discussions involving governments, and meetings organised by the pharmaceutical industry.

The NHS Patient Reported Outcome Measures (PROMs) programme, introduced in April 2009, is a significant development in the routine collection and use of patient reported outcome data. Currently, data are collected from patients both before and after surgery for four elective surgical procedures in the NHS, with plans to expand the practice.

OHE's outside activities in early 2012 focused on spillovers, HTA decision making, and measuring health outcomes.

Measuring and publishing hospital data on achieved health outcomes is becoming routine in many health care systems. League tables of hospital quality – based on post-surgical survival rates, for example - are used to highlight variation in performance across providers. These measures, however, reveal little about the health of the vast majority of patients and may fail to detect important variations in quality.

A new discussion paper from the Centre of Health Economics (CHE), University of York, reports first results from a programme of collaborative research by CHE, Nancy Devlin of the OHE, and David Parkin of NHS South of England. The study, funded by the UK Department of Health, is the first to examine the relationship between hospital costs and patients’ health outcomes.

Pages

Subscribe to RSS - EQ-5D and PROMs